Outbreak among HIV-infected patients of Staphylococcus aureus resistant to cotrimoxazole and methicillin

Infection Control and Hospital Epidemiology

Volumn 18, Issue 9, 1997, Pages 617-621

  Alonso, Roberto ^a   Padilla, Belen ^a   Sánchez Carrillo, Carlos ^a   Muñoz, Patricia ^a   Rodríguez Creixems, Marta ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CROSS INFECTION; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; PENICILLIN RESISTANCE; PROSPECTIVE STUDY; SPAIN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0031227708     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141487     Document Type: Article

References (28)

1. Boyce JM. Nosocomial staphylococcal infections. Ann Intern Med 1981;95:241-242.
2. Parras F, Rodríguez M, Bouza E, et al. Brote epidémico de Staphylococcus aureus resistente a meticilina (SARM) en un hospital general: informe preliminar. Enferm Infecc Microbiol Clin 1991;4:200-207.
3. Bouza E, Martínez-Beltrán J, the Spanish Group for the Study of Staphylococci. Staphylococci in Spain. J Chemother 1988;(suppl 4):15-17.
4. Bouza E, Martínez-Beltrán J, Grupo de Trabajo para el estudio de Estafilococos. Estudio multicéntrico sobre la prevalencia de estafilococos en España. Enferm Infecc Microbiol Clin 1988;3:68-79.
5. Diaz MD, Sánchez-Carrillo C, Bouza E, et al. Evolución de la resistencia de Staphylococcus species aislados en hospitales Españoles. Tercer estudio. Rev Clin Esp 1994;194:814-820.
6. Bouza E, Parras F. Aproximación actual al tratamiento y prevención de la infección por estafilococos resistentes a la meticilina. In: Bouza E, Rodríguez-Creixems M, eds. Staphylococcus aureus Resistente a la Meticilina: Situación Actual. Madrid, Spain: 1992:189-223.
7. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992;117:390-398.
8. Centers for Disease Control. 1993 revised CDC HIV classification system and expanded AIDS surveillance definition for adolescents and adults. MMWR 1992;41(RR-17).
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-140.
10. Ballows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ. In: Manual of Clinical Microbiology. 5th ed. Washington, DC: American Society of Microbiology; 1991:222-237.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A2. Villanova, PA: NCCLS; 1990.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard. Document M2-A4. Villanova, PA: NCCLS; 1993.
13. Pitcher DJ, Saunders NA, Owen RJ. Rapid extraction of bacterial DNA with guanidinium thiocyanate. Letters in Applied Microbiology 1989;8:151-154. Letter.
14. Alonso R, Nicholson PS, Pitt TL. Rapid extraction of high purity chromosomal DNA from Serratia marcescens. Letters in Applied Microbiology 1993;16:77-79. Letter.
15. Sambrook J, Fritsch EF, Maniatis T. In: Molecular Cloning: A Laboratory Manual. 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989. Appendices E5-E7.
16. Alonso R, Auken H, Pitt TL, Pérez-Díaz JC, Baquero F. Ribotyping on Serratia. Epidemiol Infect 1993;111:99-107.
17. Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 1990;18:7213-7218.
18. Williams JGK, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 1990;18:6531-6535.
19. Jevons MP. 'Celbenin'-resistant staphylococci. BMJ 1961;1: 124-125.
20. Wenzel RP. The emergence of methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:440-442.
21. Pérez Trallero E, Garcia Arenzana J, Ansa Castañeda A, Paisán Grisolía L. Unusual multiresistant Staphylococcus aureus in a newborn nursery. Am J Dis Child 1981;135:689-692.
22. Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-55.
23. Markowitz N, Pohlod DJ, Saravolatz LD, Quin EI. In vitro susceptibility patterns of methicillin-resistant and susceptible Staphylococcus aureus strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrob Agents Chemother 1983;23:450-457.
24. Parras F, Guerrero C, Bouza E, et al. Comparative study of mupirocin and oral cotrimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995; 39:175-179.
25. Hill RL, Duckworth GH, Casewell MW. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Agents Chemother 1988:22:377-384.
26. Samra Z, Gadba R. Antibiotic susceptibility and phage typing of methicillin-resistant Staphylococcus aureus clinical isolates from blood cultures of 692 patients in 15 Israeli hospitals. Eur J Epidemiol 1993;9:559-562.
27. Qadri SM, Halim M, Ueno Y, Saldin H. Susceptibility of methicillin-resistant Staphylococcus aureus to minocycline and other antimicrobials. Chemotherapy 1994;40:26-29.
28. Goetz MB, Mulligan ME, Kwork R, O'Brien H, Caballes C, García JP. Management and epidemiologic analysis of an outbreak due to methicillin-resistant Staphylococcus aureus. Am J Med 1992;6:607-614.